True North traces its origins back to 1999, when it was originally named India Value Fund. Today is one of India’s leading home grown private equity funds, founded with a focus on investing in and transforming mid-sized profitable businesses into world-class industry leaders, built on the strong foundation of True North Values which are embodied within the principles of ‘The Right Way’.
True North has built deep knowledge and skills in the Indian markets and has successfully launched six separate investment funds with a combined corpus of over US$ 2.8 billion including co-investments. True North’s insights and understanding of India has been sharpened over the last two decades by investing in more than 40 Indian businesses. It has successfully guided these companies in making the transition into well-established and large businesses that are valuable, enduring and socially responsible.
The company has significant focus on and extensive experience of evaluating and investing in multiple businesses across a range of segments in the Indian healthcare sector having invested over US$ 520 million across 10 companies.
The True North team has been structured with a balanced mix of 13 Investment Managers and 18 Business Managers, who bring with them several hundred man-years of industry experience.
Nayati Healthcare & Research Pvt. Ltd
Nayati is one of India’s fastest growing hospital chains providing comprehensive and world-class healthcare services. Established with the aim of taking treatment closer to people, the group is committed to providing transparent, competitive, accessible and affordable healthcare services at par with international standards to all. In a short span of time, it has grown into a 1200 bed chain and counting with hospitals in strategic locations in North India.
through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward. IQVIA enables companies to rethink approaches to clinical development and commercialization, innovate with confidence as well as accelerate meaningful healthcare outcomes. IQVIA has approximately 55,000 employees in more than 100 countries, all committed to making the potential of
human data science a reality. IQVIA’s approach to human data science is powered by the IQVIA CORE™, driving unique actionable insights at the intersection of big data, transformative technology and analytics with extensive domain expertise.
With over twenty-year presence in a country that is projected to be amongst the top three pharmaceutical markets in 2021 by YOY growth, IQVIA India takes pride in its contribution to the growth of the life sciences industry. In parallel with the growth and development of the Indian healthcare industry, our clinical and commercial services have grown and expanded to encompass a wide portfolio today. We are committed to offering innovative business models tailored to suit the local and global aspirations of our customers in a dynamic healthcare landscape. We draw on the strength and depth of our global resources, deep domain expertise and local insights to help biotech, medical device and pharmaceutical companies, consumer healthcare, medical researchers, donor and government agencies, providers, payers and other healthcare stakeholders deliver better health outcomes.
Our 11,000+ employees in India are drawn from backgrounds in life sciences, healthcare analytics, information technology and consulting that help us deliver services across clinical research, data management, lifecycle safety, medical writing, biostatistics, centralized monitoring, sales and marketing, primary intelligence, digital solutions, real world insights and consulting services. To learn more, visit www.IQVIA.com.
Ascent Health & Wellness Solutions
Ascent Health (“Ascent”) is India’s fastest growing Pharmaceutical Commerce Platform, engaged in the entire spectrum of B2B commerce across pharmacies, practitioners, hospitals and care groups. Ascents operates as a full stack - vertically integrated platform, with in-house warehousing, distribution, supply chain and owned inventory.
With deep investments in technology and constant innovation in the supply chain, Ascent today has a monthly revenue run rate in excess of INR 120 Crores, in less than five years of incorporation. The core B2B platform of the Ascent powers the commerce supply of pharmaceutical products – mainly formulations, to the 20,000+ pharmacies, and several thousand doctors and hospitals in Mumbai, Delhi, Gurugram, Bengaluru, Chennai, Davangere & Ahmedabad. Across the seven clusters of its operations, Ascent has achieved operational profitability and is well on its way todouble its scale in less than 15 months. Apart from pharmacies, Ascents’ platform power commerce and procurement decisions in multiple institutions such as govt. bodies and large format hospitals.
Ascent has also founded and made significant investments with strategic interests in providing access to affordable healthcare to consumers /patients through digital platforms. Its interests lie in some of the largest EMR providers in India and creating a troika of platforms across patient – practitioner – pharmacy.
Ascent took form in its current shape five years ago by the integration of 7 small pharmaceutical distribution units in Mumbai. By weaving a common platform enabling transparent commerce, timely supplies and assurance of 100% genuine medicines across these units, Ascent created a unique platform with compelling value. Since its launch, Ascents’ platform has seen its monthly revenue run rate more than double every 12 months, from 4 Crores in August 2014 to 120 Crores+ in August 2018, a spectacular 30x growth over the last 48 months.
What started as a simple platform providing access to medicines across 75 pharmaceutical companies, now provides more than 50,000 SKU’s across 500+ pharmaceutical companies through over 2,00,000 Sq. Feet of captive warehousing space, end-to-end cold chain management and a dedicated fleet of over 500 delivery partners. The platform has scaled up through a mix of organic and inorganic growth, having completed 12 acquisitions over a period of 24 months across 6 cities adding more depth to the coverage of its platform.
Driven by a dynamic founding and strong management team the Ascent is poised to create a paradigm shift in the way pharmaceutical commerce is powered in India. With platforms that provide access to 100% genuine products, transparent pricing, assured delivery timelines and access to multiple credit offerings, Ascent plans to touch 50,000+ pharmacies, 20,000+ doctors and hospitals in 12 cities over the next 18 months.
Ascent is building upon its leadership in to leverage the "platform" through strategic plays such in healthcare OTC, generic drugs, brand launches, data analytics, credit guarantees, CRM programs to truly create India’s best and biggest B2B healthcare commerce entity.
CitiusTech is a specialist provider of healthcare technology services and solutions, with strong presence across the globe. As a strategic partner to some of the world’s largest healthcare organizations, CitiusTech plays a deep and meaningful role in accelerating technology innovation and shaping the way healthcare is delivered to patients.
CitiusTech works at the edge of digital transformation. It focuses on multiple areas of digital technology, such as Business Intelligence, mobility & IoT, Big Data, cloud computing, predictive analytics & data science. With cutting-edge technology expertise, world-class service quality, strong consulting expertise and a global resource base, CitiusTech consistently delivers best-in-class solutions and an unmatched cost advantage to healthcare organizations worldwide.
Indium Capital is an Investment Bank focusing on Fund-Raising, Mergers & Acquisitions and Growth Strategy Advisory. We provide end-to-end services across our focus sectors: Healthcare, Consumer Brands & Technology. Indium has had significant depth of experience in these sectors, with expertise across all segments of Healthcare Delivery (hospitals, medical devices, diagnostics chains and single speciality centers), Consumer Brands (apparel, accessories, foods and other retail brands) & Technology (edu-tech, fin-tech, health-tech, etc.).
The Indium team comes from a diverse background with experience across Corporate Finance, Business Consulting & Strategy; and in the past have advised on multiple M&A and Fundraising transactions with total transaction value of over US$ 3 billion.
Dr. Lal Pathlabs Limited
Established in 1949, Dr Lal PathLabs has a network comprising over 190 Labs, over 1700 centers and 5,000+ pickup points across the country as of March 31, 2017. Backed by state-of-the-art technology, equipment and expertise of over 6 decades, it conducts over 4500 tests and has acquired the trust of over 12 million customers.
Dr Lal PathLabs has been considered as a synonym of ‘trust’ and ‘confidence’ in the field of pathology services. As a pioneer in diagnostic services, the Company offers world-class services through its team of over 3000 people.
Over the years, Dr Lal PathLabs has posted unprecedented growth and today, it is present in regions outside India as well, with centers in Oman, United Arab Emirates, Saudi Arabia, Nepal, Bangladesh, Sri Lanka and Malaysia.
Promulgating a healthier life, Dr Lal PathLabs has enabled high standards of quality with their innovative and error free test methods. Dr Lal PathLabs has been the first Indian lab to be accredited by NABL (National Accreditation Board for Testing and Calibration Laboratories) against the standard NABL 1000. It has also been accredited for National Reference Laboratory by College of American Pathologists (CAP) and carries ISO certification from BSI for the Performance of Routine and Advanced Diagnostic Pathology Testing Services and for IT Processes & Information Security at Data Center, NRL.
Backed by a strong infrastructure network, all Dr Lal PathLabs centers are connected through central server on real time basis which ensures accuracy and time bound results for the patients. This helps the company manage the entire network in an integrated manner.
MyHealthcare is an integrated digital healthcare ecosystem, a flagship product of InnoCirc Ventures. The platform is designed to work with hospitals in building out and scaling their digital healthcare roadmap. The MyHealthcare ecosystem enhances patient engagement and empowers them with their healthcare needs, through offerings such as mobile EMR, health trackers, emergency services, video consult, 24x7 health monitoring, etc. The platform helps connect healthcare givers, hospitals, diagnostics, patients and their family and brings them into a digital ecosystem. MyHealthcare has at its core a HIPAA compliant MyHealthcare SPINE that connects with HIS and offers a user-friendly patient app, a doctor app, a paramedic app, a customer website widget and an internal hospital portal (a patient support platform for the hospital team). The platform is offered on a partnership model with hospitals, whereby MyHealthcare operates as the technology partner for the hospital network across all their patient facing and care delivery services. The platform operates with a vision to improve patient care using digital technology and AI in delivering quality healthcare services.